Evidence map›Paper›PMID 32732889›Full record

ArticleNature communications2020

Targeting QKI-7 in vivo restores endothelial cell function in diabetes.

Chunbo Yang, Magdalini Eleftheriadou, Sophia Kelaini, Thomas Morrison, Marta Vilà González, Rachel Caines, Nicola Edwards, Andrew Yacoub, Kevin Edgar, Arya Moez and 8 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Estradiol Promotes Endometriosis ProgressionCurrent pharmaceutical biotechnology · 2026
    Article
  7. Beyond transcription: RNA-binding proteins steering angiogenesis.American journal of physiology. Heart and circulatory physiology · 2026
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Chunbo YangThe Wellcome-Wolfson Institute of Experimental Medicine, Belfast, BT9 7BL, UK.
Magdalini EleftheriadouThe Wellcome-Wolfson Institute of Experimental Medicine, Belfast, BT9 7BL, UK.ORCID http://orcid.org/0000-0002-3682-8489
Sophia KelainiThe Wellcome-Wolfson Institute of Experimental Medicine, Belfast, BT9 7BL, UK.ORCID http://orcid.org/0000-0002-4597-6248
Thomas MorrisonThe Wellcome-Wolfson Institute of Experimental Medicine, Belfast, BT9 7BL, UK.ORCID http://orcid.org/0000-0001-6768-4898
Marta Vilà GonzálezThe Wellcome-Wolfson Institute of Experimental Medicine, Belfast, BT9 7BL, UK.
Rachel CainesThe Wellcome-Wolfson Institute of Experimental Medicine, Belfast, BT9 7BL, UK.ORCID http://orcid.org/0000-0001-9006-1015
Nicola EdwardsCentre for Bioscience in the Department of Life Sciences, Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, M15GD, UK.ORCID http://orcid.org/0000-0002-7925-2301
Andrew YacoubThe Wellcome-Wolfson Institute of Experimental Medicine, Belfast, BT9 7BL, UK.ORCID http://orcid.org/0000-0002-8780-3484
Kevin EdgarThe Wellcome-Wolfson Institute of Experimental Medicine, Belfast, BT9 7BL, UK.ORCID http://orcid.org/0000-0002-8057-0104
Arya MoezThe Wellcome-Wolfson Institute of Experimental Medicine, Belfast, BT9 7BL, UK.
Aleksandar IveticSchool of Cardiovascular Medicine and Sciences, BHF Centre of Research Excellence, King's College London, The James Black Centre, 125 Coldharbour Lane, London, SE5 9NU, UK.ORCID http://orcid.org/0000-0001-9844-6518
Anna ZampetakiSchool of Cardiovascular Medicine and Sciences, BHF Centre of Research Excellence, King's College London, The James Black Centre, 125 Coldharbour Lane, London, SE5 9NU, UK.ORCID http://orcid.org/0000-0002-7257-8624
Lingfang ZengSchool of Cardiovascular Medicine and Sciences, BHF Centre of Research Excellence, King's College London, The James Black Centre, 125 Coldharbour Lane, London, SE5 9NU, UK.ORCID http://orcid.org/0000-0002-0390-4561
Fiona L WilkinsonCentre for Bioscience in the Department of Life Sciences, Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, M15GD, UK.
Noemi LoisThe Wellcome-Wolfson Institute of Experimental Medicine, Belfast, BT9 7BL, UK.ORCID http://orcid.org/0000-0003-2666-2937
Alan W StittThe Wellcome-Wolfson Institute of Experimental Medicine, Belfast, BT9 7BL, UK.
David J GrieveThe Wellcome-Wolfson Institute of Experimental Medicine, Belfast, BT9 7BL, UK.ORCID http://orcid.org/0000-0002-3655-7754
Andriana MargaritiThe Wellcome-Wolfson Institute of Experimental Medicine, Belfast, BT9 7BL, UK. a.margariti@qub.ac.uk.ORCID http://orcid.org/0000-0001-9303-8371
King's College London · GBManchester Metropolitan University · GBWellcome Trust · GB

Funding

Biotechnology and Biological Sciences Research CouncilBritish Heart Foundation FS/13/18/30207British Heart Foundation FS/14/35/30813British Heart Foundation FS/15/23/31435British Heart Foundation PG/14/78/31099British Heart Foundation PG/15/18/31333British Heart Foundation PG/15/3/31226British Heart Foundation PG/16/8/31985British Heart Foundation PG/18/29/33731British Heart Foundation PG/19/56/34550British Heart Foundation PG/19/61/34586Medical Research Council MC_PC_13075Medical Research Council MC_PC_15035Medical Research Council MC_PC_19050
6 · The paper itself

Abstract

Vascular endothelial cell (EC) dysfunction plays a key role in diabetic complications. This study discovers significant upregulation of Quaking-7 (QKI-7) in iPS cell-derived ECs when exposed to hyperglycemia, and in human iPS-ECs from diabetic patients. QKI-7 is also highly expressed in human coronary arterial ECs from diabetic donors, and on blood vessels from diabetic critical limb ischemia patients undergoing a lower-limb amputation. QKI-7 expression is tightly controlled by RNA splicing factors CUG-BP and hnRNPM through direct binding. QKI-7 upregulation is correlated with disrupted cell barrier, compromised angiogenesis and enhanced monocyte adhesion. RNA immunoprecipitation (RIP) and mRNA-decay assays reveal that QKI-7 binds and promotes mRNA degradation of downstream targets CD144, Neuroligin 1 (NLGN1), and TNF-α-stimulated gene/protein 6 (TSG-6). When hindlimb ischemia is induced in diabetic mice and QKI-7 is knocked-down in vivo in ECs, reperfusion and blood flow recovery are markedly promoted. Manipulation of QKI-7 represents a promising strategy for the treatment of diabetic vascular complications.

Indexed as

AnimalsAntigens, CDAtherosclerosisCadherin 5CadherinsCell Adhesion MoleculesCell Adhesion Molecules, NeuronalCells, CulturedDiabetes Mellitus, ExperimentalEndothelial CellsGene Expression RegulationHumansHyperglycemiaIschemiaMaleMiceAntigens, CDCadherin 5CadherinsCell Adhesion MoleculesCell Adhesion Molecules, Neuronalneuroligin 1Qk protein, mouseRNA-Binding ProteinsRNA, MessengerRNA, Small InterferingTnfaip6 protein, mouse

Identifiers

PMID32732889
PMCPMC7393072
OpenAlexW3046132906

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.